vs
Side-by-side financial comparison of Elevance Health (ELV) and MANULIFE FINANCIAL CORP (MFC). Click either name above to swap in a different company.
Elevance Health is the larger business by last-quarter revenue ($49.7B vs $29.4B, roughly 1.7× MANULIFE FINANCIAL CORP). MANULIFE FINANCIAL CORP runs the higher net margin — 12.1% vs 1.1%, a 11.0% gap on every dollar of revenue.
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon.
Manulife Financial Corporation is a Canadian multinational insurance company and financial services provider headquartered in Toronto, Ontario. The company operates in Canada and Asia as "Manulife" and in the United States primarily through its John Hancock Financial division. As of December 2021, the company employed approximately 38,000 people and had 119,000 agents under contract, and has CA$1.4 trillion in assets under management and administration. Manulife at one point serviced over 26 ...
ELV vs MFC — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2022
| Metric | | |
|---|---|---|
| Revenue | $49.7B | $29.4B |
| Net Profit | $547.0M | $3.5B |
| Gross Margin | 88.9% | — |
| Operating Margin | 0.6% | — |
| Net Margin | 1.1% | 12.1% |
| Revenue YoY | 1.8% | — |
| Net Profit YoY | -74.9% | — |
| EPS (diluted) | $2.56 | $1.83 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $49.7B | — | ||
| Q4 25 | $49.7B | — | ||
| Q3 25 | $50.7B | — | ||
| Q2 25 | $49.8B | — | ||
| Q1 25 | $48.9B | — | ||
| Q4 24 | $45.4B | — | ||
| Q3 24 | $45.1B | — | ||
| Q2 24 | $43.9B | — |
| Q1 26 | $547.0M | — | ||
| Q4 25 | $547.0M | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $418.0M | — | ||
| Q3 24 | $1.0B | — | ||
| Q2 24 | $2.3B | — |
| Q1 26 | 88.9% | — | ||
| Q4 25 | 88.9% | — | ||
| Q3 25 | 89.4% | — | ||
| Q2 25 | 89.4% | — | ||
| Q1 25 | 89.8% | — | ||
| Q4 24 | 86.8% | — | ||
| Q3 24 | 88.7% | — | ||
| Q2 24 | 89.0% | — |
| Q1 26 | 0.6% | — | ||
| Q4 25 | 0.6% | — | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | 4.9% | — | ||
| Q1 25 | 6.5% | — | ||
| Q4 24 | 1.5% | — | ||
| Q3 24 | 3.1% | — | ||
| Q2 24 | 6.3% | — |
| Q1 26 | 1.1% | — | ||
| Q4 25 | 1.1% | — | ||
| Q3 25 | 2.3% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | 5.2% | — |
| Q1 26 | $2.56 | — | ||
| Q4 25 | $2.56 | — | ||
| Q3 25 | $5.32 | — | ||
| Q2 25 | $7.72 | — | ||
| Q1 25 | $9.61 | — | ||
| Q4 24 | $1.88 | — | ||
| Q3 24 | $4.36 | — | ||
| Q2 24 | $9.85 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $9.5B | — |
| Total DebtLower is stronger | $31.9B | — |
| Stockholders' EquityBook value | $43.9B | — |
| Total Assets | $121.5B | — |
| Debt / EquityLower = less leverage | 0.73× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $9.5B | — | ||
| Q4 25 | $9.5B | — | ||
| Q3 25 | $8.7B | — | ||
| Q2 25 | $8.6B | — | ||
| Q1 25 | $7.5B | — | ||
| Q4 24 | $8.3B | — | ||
| Q3 24 | $7.9B | — | ||
| Q2 24 | $6.5B | — |
| Q1 26 | $31.9B | — | ||
| Q4 25 | $31.9B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $30.9B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $43.9B | — | ||
| Q4 25 | $43.9B | — | ||
| Q3 25 | $44.0B | — | ||
| Q2 25 | $43.7B | — | ||
| Q1 25 | $42.5B | — | ||
| Q4 24 | $41.3B | — | ||
| Q3 24 | $43.8B | — | ||
| Q2 24 | $42.2B | — |
| Q1 26 | $121.5B | — | ||
| Q4 25 | $121.5B | — | ||
| Q3 25 | $122.7B | — | ||
| Q2 25 | $121.9B | — | ||
| Q1 25 | $119.7B | — | ||
| Q4 24 | $116.9B | — | ||
| Q3 24 | $116.5B | — | ||
| Q2 24 | $113.0B | — |
| Q1 26 | 0.73× | — | ||
| Q4 25 | 0.73× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.75× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $13.2K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 0.00× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $84.0M | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $1.0B | — | ||
| Q4 24 | $706.0M | — | ||
| Q3 24 | $2.7B | — | ||
| Q2 24 | $447.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | $-209.0M | — | ||
| Q3 25 | $775.0M | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $821.0M | — | ||
| Q4 24 | $384.0M | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $124.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | -0.4% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 3.6% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | 0.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.95× | — | ||
| Q2 25 | 1.18× | — | ||
| Q1 25 | 0.47× | — | ||
| Q4 24 | 1.69× | — | ||
| Q3 24 | 2.63× | — | ||
| Q2 24 | 0.19× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
